APA (7th ed.) Citation

M, F., M, P., L, Q., F, O., JA, G., L, C., . . . PI, K. (2026). Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era. Annals of surgical oncology. https://doi.org/10.1245/s10434-026-20341-9

Chicago Style (17th ed.) Citation

M, Filzmayer, et al. "Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era." Annals of Surgical Oncology 2026. https://doi.org/10.1245/s10434-026-20341-9.

MLA (9th ed.) Citation

M, Filzmayer, et al. "Risk-Adapted Use of Adjuvant Systemic Therapy After Nephrectomy for Renal Cell Carcinoma: A Population-Based Study in the Post-approval Era." Annals of Surgical Oncology, 2026, https://doi.org/10.1245/s10434-026-20341-9.